Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis.

Kefyalew Addis AleneKerri VineyDarren J GrayEmma S McBrydeZuhui XuArchie C A Clements

Published in: PloS one (2020)

History of second-line TB treatment, resistance to any fluoroquinolones, and smear non-conversion at two months can be used to estimate the risk of poor treatment outcome in patients with MDR-TB with a moderate degree of accuracy (AUROC = 0.69).

Keyphrases

multidrug resistant
mycobacterium tuberculosis
pulmonary tuberculosis
drug resistant
acinetobacter baumannii
gram negative
klebsiella pneumoniae
hiv aids
emergency department
combination therapy
cystic fibrosis
human immunodeficiency virus
adverse drug
replacement therapy
electronic health record